Naz News, Gappers and FLE's

[sludgehound]

THOR Crushed AH 24 from C 32.57 -0.49

Above average vol day 89% institutional. beta 0.9 OS 59M
16:29
Thoratec Misses Q2 Sales Estimates, Matches on EPS But Warns of FY Shortfall; OKs Accelerted Share Buyback and Starts HeartMate PHP Study - Shares Due Off Halt at 430 PM ET

FY sales are seen between $455 million to $470 million, below predictions for $523 million. Non-GAAP EPS are seen between $1.25 to $1.35, missing forecasts for $1.75.
Separately, it says its CE mark clinical trial for HeartMate PHP (Percutaneous Heart Pump) has commenced. It also has entered into a $30 million Accelerated Share Repurchase (ASR) agreement.
Shares are due off a trading halt at 430 PM ET.
Price: 32.57, Change: , Percent Change:
http://www.mtnewswires.com © 2014 MT Newswires, a Division of MidnightTrader, Inc. All rights reserved.
------------
4:33p
*Thoratec Shares Resume Trading; Now Down 18% (Benzinga)

4:15p
*PREVIEW: Thoratec to Resume Trading at 4:30 PM ET (Benzinga)

4:08p
Thoratec Sees FY14 Adj EPS $1.25-Adj EPS $1.35 >THOR (Dow Jones)

4:07p
Thoratec 2Q Adj EPS 43c >THOR (Dow Jones)

4:07p
Thoratec Sees FY14 Rev $455M-$470M >THOR (Dow Jones)

4:07p
Thoratec Sees FY14 EPS 80c-EPS 90c >THOR (Dow Jones)

4:05p
Thoratec Says $20M Accelerated Repurchase Program to Be Finished During 3Q >THOR (Dow Jones)

4:03p
*Thoratec Announces Starting CE Mark Clinical Trial (Benzinga)

4:02p
Thoratec Corporation Reports Q2 EPS of $0.43, Inline; Revenue of $118.10M vs $128.25M Est, $30M Accelerated Buyback (Benzinga)

4:02p
Thoratec Announces $30 Million Accelerated Share Repurchase (PR NewsWire)

4:02p
Thoratec(R) Reports Second Quarter 2014 Results (PR NewsWire)

4:02p
Thoratec 2Q EPS 30c >THOR (Dow Jones)

4:02p
Thoratec 2Q Net $17.4M >THOR (Dow Jones)

4:02p
Thoratec Announces $30 Million Accelerated Share Repurchase >THOR (Dow Jones)

4:02p
Thoratec 2Q Sales $118.1M >THOR (Dow Jones)

4:02p
Press Release: Thoratec(R) Reports Second Quarter 2014 Results (Dow Jones)

4:02p
Press Release: Thoratec(R) Reports Second Quarter -2- (Dow Jones)

4:02p
Press Release: Thoratec(R) Reports Second Quarter -3- (Dow Jones)

4:02p
Press Release: Thoratec(R) Reports Second Quarter -4- (Dow Jones)

4:01p
*Thoratec Halted, News Pending (Benzinga)